Brand-name drug
Savella price, strengths & recalls
Brand of milnacipran (generic)
Pharmacies pay $244.50 for 30 tablets of Savella 100 mg tablet this week, and from $8.15 to $245.15 across its 5 priced strengths and forms. The generic, milnacipran, costs pharmacies from $36.45. Its official label last changed on August 27, 2026.
Brand- Fair cash price
- $291.68
- Strengths
- 5
- Makers
- 1
- Updated
- Nov 11
Savella price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 4-week titration pack Brand | $8.15 | $8.15 / 1 kit |
| 12.5 mg tablet Brand | $8.17 | $245.15 / 30 tablets |
| 25 mg tablet Brand | $8.15 | $244.52 / 30 tablets |
| 50 mg tablet Brand | $8.16 | $244.68 / 30 tablets |
| 100 mg tablet Brand | $8.15 | $244.50 / 30 tablets |
The lowest cost per tablet is 100 mg tablet at $8.15. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Savella vs generic milnacipran
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
| Strength | Brand | Generic | Brand costs |
|---|---|---|---|
| 12.5 mg tablet | $245.15 | $36.45 | 6.7x |
| 25 mg tablet | $244.52 | $71.52 | 3.4x |
| 50 mg tablet | $244.68 | $84.90 | 2.9x |
| 100 mg tablet | $244.50 | $81.81 | 3x |
Supply status: shortages & recalls
What people paid for Savella
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use SAVELLA safely and effectively. See full prescribing information for SAVELLA. SAVELLA® (milnacipran HCl) tabletsInitial U.S. Approval: 2009
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS
SAVELLA is a selective serotonin and norepinephrine reuptake inhibitor (SNRI), similar to some drugs used for the treatment of depression and other psychiatric disorders. Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of such drugs in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on SAVELLA should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. SAVELLA is not approved for use in the treatment of major depressive disorder. SAVELLA is not approved for use in pediatric patients [see Indications and Usage (1), Warnings and Precautions (5.1), Use in Specific Populations (8.4)].
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS
See full prescribing information for complete boxed warning.
Increased risk of suicidal ideation, thinking, and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders (5.1).
SAVELLA is not approved for use in pediatric patients (1, 8.4).
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA022256 · Abbvie
- First approved
- January 14, 2009 (17 years ago)
- Latest approved change
- September 10, 2025
- Approved label
- PDF, Sep 11, 2025
- Generic makers
- 3 approved generic applications on the market
- Last patent listed
- September 19, 2029
Savella questions
How much does savella cost without insurance?
Pharmacies pay about $244.50 for 30 tablets of savella 100 mg tablet ($8.15 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $291.68. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Savella?
Yes: milnacipran. Pharmacies pay from $36.45 for it. Compare milnacipran prices.
Is savella in shortage?
No shortage is reported for savella right now. We check the national shortage list every day.
Has savella been recalled?
No recalls are on record for savella.
When did the savella label last change?
The official label was last updated on August 27, 2026 (version 41). See what changed.
Talk about savella
No comments yet. Questions, tips, what worked for you - start the conversation.